cases were matched in age, etiology and morbidity profile. Mean age was 34 years (range 27 to 52). Overall follow up was 25 months (range 16-54). Average length of stricture was 4.6 cm (range 3.1 to 8.3). Length of the obliterated segment was 2.5 cm (range 1.1 to 3.2). Success rate was 90 % in group A and 88 % in group B. Complication rate was 5 % in group A and 7 % in group B. Complications noted were wound infection, donor site pain. Main disadvantage of ventral approach was in very narrow or completely obliterated cases where the urethral strip was too narrow for the double grafting. Therefore dorsal approach was preferred in these cases.
INTRODUCTION AND OBJECTIVES:
Recent literature reflects increasing rates of outpatient anastomotic urethroplasty. However, graft urethroplasty remains primarily an inpatient procedure. We sought to compare outcomes between inpatient and outpatient buccal mucosal graft (BMG) urethroplasty in a large tertiary care center.
METHODS: We performed a retrospective review of all patients who underwent BMG urethroplasty at our tertiary center between 2007 and 2018. Patients were divided into inpatient (including 23 hour stay) and outpatient groups. Demographics and outcomes were collected and analyzed, with success defined as functional voiding with no additional interventions. We also evaluated rates of post-operative clinical encounters including telephone calls, electronic messages, ER visits and re-admissions.
RESULTS: Among 149 patients undergoing BMG urethroplasty, 88 cases (59.1%) were performed on an inpatient basis, and 61 cases (40.9%) on an outpatient basis. Patient characteristics were similar between the two groups. Success was comparable in the two groups (75% inpatient vs. 79% outpatient, p[0.38), though median follow-up was longer in the inpatient group compared to the outpatient group (73.6 mo vs. 26.2 mo, p<0.001). Rates of major, minor, and overall complications were similar between groups (30.7% inpatient, 26.2% outpatient, p[0.34). On multivariate logistic regression analysis, prior pelvic radiation was predictive of stricture recurrence (OR 8.33, p[0.03) , but outpatient BMG urethroplasty was not predictive. There was no difference in rates of post-operative clinical encounters at 3, 6 and 12 months between both groups. CONCLUSIONS: BMG urethroplasty can be safely performed on an ambulatory basis without increased complications or compromised outcomes. We now reserve inpatient BMG urethroplasty for patients with significant medical comorbidity or elevated BMI who warrant post-anesthesia observation. METHODS: We reviewed of our prospectively maintained urethroplasty database for all patients who underwent staged urethroplasty. Routine follow-up included a cystoscopy 4 months after their 2nd stage to ensure early success, and then annual follow-up thereafter with post-void residual and symptom assessment. Repeat cystoscopy is performed for any patient who has significant worsening of symptoms to ensure symptoms were not from recurrence. Primary outcome was success, which was defined as recurrent stricture that prevented easy passage of a 16 Fr cystoscope at any point during follow-up. Stricture characteristics, etiology and the need for split thickness skin grafts (STSG) versus buccal mucosal grafting (BMG) alone were analyzed with regards to success. RESULTS: Forty-nine patients were eligible for inclusion, 65.3% (n[32) who had a diagnosis of hypospadias, 20.4% (n[10) had lichen sclerosis (LS), and 14.3% (n[7) had very complex strictures in the absence of either diagnosis. The mean stricture length was 8.7 cm (2 to 25 cm). Early success rate demonstrated by cystoscopy at 4 months was 100%, and the long-term success rate was 81.6% with a mean follow-up of 31.7 months (range 4 to 141.6). Longer strictures were associated with STSG used versus BMG alone (11.9 cm versus 5.7 cm, p<0.001). A subset analysis was performed to compare those who had STSG as part of their repair to those who only had BMG, which revealed a significantly higher success rate in those who were treated exclusively with BMG (100% vs. 64%, p<0.01). On univariate analysis, strictureINTRODUCTION AND OBJECTIVES: The optimal approach to treatment of bulbar urethral strictures remains controversial. In this study we describe our institutional experience and compare outcomes with a transecting (figure 1) versus non-transecting (figure 2) bulbar urethroplasty algorithm.
METHODS: Retrospective review identified 472 patients treated with anterior urethroplasty by a single surgeon from 2003-2018. Patients were included if the stricture involved the bulbar urethra and had a minimum follow up of 6 mo. Exclusion criteria were panurethral stricture, prior radiation or urethral stent. Patient demographics, procedure characteristics and outcomes were reviewed. The primary endpoint was stricture resolution. Success was defined as freedom from secondary procedures including dilation, urethrotomy, or repeat urethroplasty.
RESULTS: May 2013 was identified as the transition point to our current non-transecting algorithm. There were 188 patients who met the inclusion criteria. There were 99 non-transecting cases and 89 cases from the transecting era that served as the control group. In the transecting vs. non-transecting cohorts, the average age was 41 vs 47, previous urethroplasty 18% vs. 18%, traumatic strictures 25% vs. 30%. Time to urethral catheter removal and 30-day complication rates were similar. The mean stricture length increased from 2.5 to 4.4 cm. The success rate in the transecting vs. non-transecting cohorts was 84% at mean follow up 7 mo vs. 89% at mean follow up 55 mo. KaplaneMeier survival estimates demonstrate no statistical difference in time to stricture recurrence in the transecting versus non-transecting groups (p [ 0.21).
CONCLUSIONS: In this retrospective series, transecting and non-transecting primary bulbar urethroplasty resulted in similar stricture resolution rate. Prospective studies are needed to determine what differences may present in outcomes related to sexual function and long-term success.
Source of Funding: None

MP67-11 RISK FACTORS FOR DE NOVO SEXUAL DYSFUNCTION IN TRANSECTING BULBAR URETHROPLASTY
James Furr*, Quynh Mai, Phil Bucur, Joel Gelman, Orange, CA INTRODUCTION AND OBJECTIVES: Recent comparative data has shown that transecting anastomotic urethroplasty may be a risk factor for developing sexual dysfunction. We aim to identify patients at risk for sexual dysfunction following transecting urethroplasty.
METHODS: A prospectively maintained urethroplasty database was queried isolating patients undergoing transecting excision and primary anastomosis for bulbar urethral strictures from 2000 to 2018. Primary outcomes were success rate and satisfaction. Patients were differentiated based on a 1 layer non-bulbar artery sparing versus 2 layer, bulbar artery sparing technique as well as age, stricture length and prior intervention. Success was defined as urethral patency of >16 Fr on cystoscopy at 4 months, and subsequently if symptoms returned. Secondary outcomes were de novo sexual dysfunction assessed at 4 months then yearly, and was defined with questions After surgery, have noticed any negative changes in sexual activity? and Have you had problems with erections after surgery which were not present before?. Validated patient reported outcome measures were also collected. Comparisons between patients with sexual dysfunction were performed using t-test, chi-square and multivariable logistic regression.
RESULTS: 155 patients were included with success rate of 98% and overall patient satisfaction of 93%. Mean stricture length of 1.8 cm (95% CI 1.6-2.1) and average age was 41.3 years. The average follow up was 60 (95% CI 51-69) months. The incidence of de novo sexual dysfunction was 25%. Patients with sexual dysfunction were more likely to undergo 1 layer non-bulbar artery sparing technique, >50 years and stricture length >1.5cm. Comparative results are summarized in Table 1 . On multivariable logistic regression analysis, stricture length > 1.5cm (OR 2.8, p[0.02) and 1 layer technique (OR 2.56 p[0.025) were independently associated with sexual dysfunction. Sexual dysfunction was closely associated with patient satisfaction (p[0.004).
CONCLUSIONS: Transecting anastamotic urethroplasty is effective with overall high patient satisfaction. However, de novo sexual dysfunction can be a problematic issue in at-risk patients. Nontransecting or 2 layer techniques should be considered in patients who are at risk for sexual dysfunction.
